PharmaTher Holdings Ltd.

PharmaTher Holdings Ltd.verified

PHRRF

Price:

$0.166

Market Cap:

$20.54M

PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company's product in pipeline includes Ketamine intravenous injection, which is in Phase II and III clinical trials for Parkinson's disease, anesthesia and sedation, and amyotrophic lateral sclerosis indications. Its pipeline also comprises Ketamine Patch that is in Phase I and II clinical trials for treating depression, mental health, complex regional pain syndrome, and pain disorders; and Ketamine Pump, which is in Phase II clinical...[Read more]

Industry

Biotechnology

IPO Date

2021-01-08

Stock Exchange

PNK

Ticker

PHRRF

The Enterprise Value as of November 2024 (TTM) for PharmaTher Holdings Ltd. (PHRRF) is 18.74M

According to PharmaTher Holdings Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 18.74M. This represents a change of 19.94% compared to the average of 15.63M of the last 4 quarters.

PharmaTher Holdings Ltd. (PHRRF) Historical Enterprise Value (quarterly & annually)

How has PHRRF Enterprise Value performed in the past?

The mean historical Enterprise Value of PharmaTher Holdings Ltd. over the last ten years is 10.13M. The current 18.74M Enterprise Value has changed 18.40% with respect to the historical average. Over the past ten years (40 quarters), PHRRF's Enterprise Value was at its highest in in the August 2021 quarter at 66.18M. The Enterprise Value was at its lowest in in the November 2022 quarter at 876.86K.

Quarterly (TTM)
Annual

Average

10.13M

Median

7.93M

Minimum

1.91M

Maximum

19.80M

PharmaTher Holdings Ltd. (PHRRF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of PharmaTher Holdings Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 324.57%

Maximum Annual Enterprise Value = 19.80M

Minimum Annual Increase = -90.36%

Minimum Annual Enterprise Value = 1.91M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202417.01M324.57%
20234.01M109.97%
20221.91M-90.36%
202119.80M149.57%

PharmaTher Holdings Ltd. (PHRRF) Average Enterprise Value

How has PHRRF Enterprise Value performed in the past?

The current Enterprise Value of PharmaTher Holdings Ltd. (PHRRF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

7.64M

5-year avg

10.13M

10-year avg

10.13M

PharmaTher Holdings Ltd. (PHRRF) Enterprise Value vs. Peers

How is PHRRF’s Enterprise Value compared to its peers?

PharmaTher Holdings Ltd.’s Enterprise Value is greater than Adial Pharmaceuticals, Inc. (1.27M), greater than TransCode Therapeutics, Inc. (4.92M), greater than Aditxt, Inc. (14.61M), less than Reviva Pharmaceuticals Holdings, Inc. (33.37M), greater than Avenue Therapeutics, Inc. (1.25M), less than Tryp Therapeutics Inc. (0), greater than PsyBio Therapeutics Corp. (7.59M), greater than Awakn Life Sciences Corp. (435.02K), greater than XOMA Corporation (4.81M), less than Fortress Biotech, Inc. (332.73M), less than Checkpoint Therapeutics, Inc. (57.12M), less than ZIVO Bioscience, Inc. (175.79M), less than Lumos Pharma, Inc. (73.95M), less than Wesana Health Holdings Inc. (23.89M), greater than BioVaxys Technology Corp. (255.22K), greater than GH Research PLC (17.41M), less than Algernon Pharmaceuticals Inc. (392.97M), greater than AXIM Biotechnologies, Inc. (1.14M), greater than Regen BioPharma, Inc. (7.10M), greater than Regen BioPharma, Inc. (1.53M), greater than Mymetics Corporation (3.66M), less than ProtoKinetix, Incorporated (75.05M), greater than null (3.46M),

Build a custom stock screener for PharmaTher Holdings Ltd. (PHRRF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PharmaTher Holdings Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PharmaTher Holdings Ltd. (PHRRF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PharmaTher Holdings Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is PharmaTher Holdings Ltd.'s Enterprise Value?

What is the highest Enterprise Value for PharmaTher Holdings Ltd. (PHRRF)?

What is the 3-year average Enterprise Value for PharmaTher Holdings Ltd. (PHRRF)?

What is the 5-year average Enterprise Value for PharmaTher Holdings Ltd. (PHRRF)?

How does the current Enterprise Value for PharmaTher Holdings Ltd. (PHRRF) compare to its historical average?